Aurora Financial JournalNavamedic ASA (NAVA.OL)
Oslo Børs · Financial statements, TTM figures and earnings dates
In fiscal year 2024 (ended December 31, 2024), Navamedic ASA reported revenue of NOK 531.4M and net income of −NOK 5.5M. Annual financial statements are available for fiscal years 2020 to 2024, taken from the company's ESEF annual reports (IFRS).
Open interactive financials →Key financials
| NOK | FY2024 2024-12-31 | FY2023 2023-12-31 | FY2022 2022-12-31 | FY2021 2021-12-31 | FY2020 2020-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | NOK 531.4M | NOK 512.0M | NOK 382.1M | NOK 278.4M | NOK 209.9M |
| Operating income | NOK 31.8M | NOK 23.6M | NOK 44.4M | NOK 11.5M | −NOK 4.9M |
| Net income | −NOK 5.5M | −NOK 13.7M | NOK 29.4M | NOK 618.0K | −NOK 16.5M |
| Diluted EPS | −NOK 0.31 | −NOK 0.79 | NOK 1.73 | NOK 0.04 | −NOK 1.14 |
| Cash flow | |||||
| Operating cash flow | NOK 39.4M | NOK 2.2M | NOK 17.9M | −NOK 1.3M | −NOK 3.2M |
| Balance sheet | |||||
| Cash and equivalents | NOK 37.3M | NOK 38.0M | NOK 55.3M | NOK 52.6M | NOK 39.6M |
| Total assets | NOK 467.5M | NOK 507.3M | NOK 382.8M | NOK 330.2M | NOK 260.0M |
| Total liabilities | NOK 250.8M | NOK 301.9M | NOK 173.1M | NOK 178.9M | NOK 130.6M |
| Total debt | NOK 114.0M | NOK 146.5M | NOK 52.0M | NOK 39.0M | NOK 20.9M |
| Shareholders' equity | NOK 216.7M | NOK 205.4M | NOK 209.7M | NOK 151.2M | NOK 129.5M |
TTM = trailing twelve months (balance-sheet items at the latest quarter end). Figures in NOK as reported; per-share data adjusted for stock splits.
Annual reports
More on the interactive page
The full NAVA.OL page on Aurora Financial Journal includes every fiscal year since the company began filing structured data, income statement, balance sheet and cash flow statement line by line, charts for every measure, valuation multiples (P/E, P/S, P/B), live price charts and the earnings calendar.
Open NAVA.OL financials →